CohBar Inc. is a clinical stage biotechnology company developing innovative therapeutics to fight age-related diseases. With a focus on mitochondrial-based therapies, the company aims to address unmet medical needs in diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Backed by a team of experienced scientists and a diverse pipeline of drug candidates, CohBar is poised to make a significant impact in the field of anti-aging therapeutics.
Notification